Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • COVID-19 and osteoporosis

“Are osteoporosis screening and treatment vital?”

    • Geriatrics
    • News
    • Orthopedics
    • RX
  • 2 minute read

Prof. Dr. med. Kurt Lippuner, Director and Chief Physician at the University Clinic for Osteoporosis at the Inselspital Bern answers this question in an interview with

OsteoSwiss

 with, “In many cases, yes.” He goes on to explain that mortality is far higher in osteoporosis than in COVID-19, so workup and ongoing treatment are essential despite the current situation. How can the treatment be maintained at the moment?

Prof. Dr. med. Kurt Lippuner further explains that if a femoral neck breaks due to a missed diagnosis or therapy, the mortality within the first year is on average 20%. The older the patients, the higher the mortality.

According to Prof. Lippuner, it would therefore be a serious omission from a medical point of view to omit treatment with antiresorptives, i.e., to omit a due Prolia®-Do not administer zoledronate injection or zoledronate infusion. He further emphasizes that it would be irresponsible to postpone osteoporosis diagnosis and initiation of therapy indefinitely, both in patients who have recently experienced a fracture and in patients at imminent risk of fracture. As with other serious chronic diseases, he says, ongoing treatment is essential despite the current situation. See: OsteoSwiss

However, many physicians report that maintaining osteoporosis treatment can be very challenging at the moment.

Self-Injection & HomeCare

In the event that continuation of therapy is not possible in practice, Amgen has worked with experts to develop specific solutions for Prolia® treatment. Since the administration of Prolia® may also be performed by patients with appropriate instruction, for example, the

instruction video

for the self-administration of Prolia® is provided
.1 

The video may begiven to patients or their relativesforeducational purposes .1 Further documentation on patient education is available for download here as well as the patient information here

Not all patients want to perform self-application. As an alternative, Amgen points to the Zur Rose pharmacy, which offers a home delivery service as well as the option for therapy accompaniment by telephone or Prolia® administration by nursing staff directly at patients’ homes. A form for prescribing this specialty care service is 

here

 to find.

Other providers such as the 

Spitex

 or 

PharmOnline.ch

 also play a major role in providing continuous patient care in these challenging times.

References and brief subject info

1 Prolia® Professional Information, August 2019. www.swissmedicinfo.ch

CH-PRO-0420-00001 (04/2020)

Previous Article
  • Chronic heart failure

Telemonitoring helps reduce mortality risk

  • Cardiology
  • Congress Reports
  • RX
View Post
Next Article
  • Lymph node swelling

Benign hyperplasia or serious systemic disease? A search for traces…

  • Education
  • General Internal Medicine
  • Oncology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 7 min
  • Gonarthrosis and coxarthrosis: update on conservative treatment

Pain relief, targeted movement and relief

    • General Internal Medicine
    • Geriatrics
    • Orthopedics
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
View Post
  • 4 min
  • Idiopathic and progressive pulmonary fibrosis (IPF/PPF)

An instrument for clinical use

    • Education
    • Pneumology
    • RX
    • Studies
View Post
  • 7 min
  • Rosacea - multifaceted and multifactorial

Topical and systemic active ingredients: proven and new therapeutic approaches

    • Dermatology and venereology
    • Education
    • Infectiology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 14 min
  • Lung cancer

Multidisciplinary teams in oncology

    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Nuclear Medicine
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Surgery
    • Urology
View Post
  • 6 min
  • From diagnostics to personalized therapy

Nuclear medical imaging for Parkinson’s disease

    • Education
    • Neurology
    • Nuclear Medicine
    • Pharmacology and toxicology
    • Radiology
    • RX
    • Studies
View Post
  • 7 min
  • Psoriasis in difficult localizations: Nail psoriasis

IL-23 and IL-17 as a target – selected study findings

    • Dermatology and venereology
    • Education
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 4 min
  • Artificial intelligence in diabetes prevention

Lifestyle interventions are better accepted with AI

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Prevention and health care
    • RX
    • Studies
View Post
  • 9 min
  • B-cell lymphomas

Bispecific antibodies – mechanisms, evidence and future role

    • Education
    • Hematology
    • Oncology
    • RX
    • Studies
Banner Landingpage Kurzfachinfo
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Clinical care from birth to adulthood
  • 2
    Multidisciplinary teams in oncology
  • 3
    Multidisciplinary teams in oncology
  • 4
    What is tested when and on whom?
  • 5
    Molecular mechanisms of tumor plasticity

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.